Kids climb Everest

Credit: Courtesy of Janeet Stocks" /> Credit: Courtesy of Janeet Stocks On the first day of school after spring break, nine British children had an unusual tale to tell regarding "what I did on my vacation": They climbed Mount Everest. At least part of it, that is. Ranging in age from 6 to 13 years, the kids were part of an expedition that Janet Stocks led. As a professor of respiratory physiology at University College London, Stocks designed a study to investigate how

Written byAndrea Gawrylewski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On the first day of school after spring break, nine British children had an unusual tale to tell regarding "what I did on my vacation": They climbed Mount Everest. At least part of it, that is.

Ranging in age from 6 to 13 years, the kids were part of an expedition that Janet Stocks led. As a professor of respiratory physiology at University College London, Stocks designed a study to investigate how children breathe and sleep at high altitudes. Stocks says the study will provide data on the short-term effects of high-altitude exposure in children with lung conditions, a poorly-understood subject that becomes critical when the children visit higher altitudes, or even travel by airplane.

Under blue Nepalese skies, the group hiked from Lukla to Namache Bazaar and finally to Tengboche, at 3,860 meters elevation, a round-trip journey that took three weeks. Along the way, local Sherpa guides carried the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies